Prolonged excess weight accompanied by metabolic disorders demonstrably accelerates biological ageing through inflammation, oxidative stress, telomere shortening and cellular senescence. Metabolically healthy excess weight, however, does not appear to cause accelerated frailty progression, indicating that metabolic health matters more than weight alone.
Overweight and obesity have been associated with accelerated biological ageing in multiple studies. In a Chilean birth cohort study of young adults aged 28 to 31 years (n=205), prolonged obesity (on average from age 12 to 27 years) led to significantly higher levels of inflammatory markers such as hs-CRP and IL-6, with large effect sizes (Cohen f 0.53 to 0.57). Abnormalities were also measured in epigenetic age and telomere length, two widely used measures of biological ageing. This suggests that the damage begins early in life (PMID 40643913).
At the molecular level, obesity causes oxidative stress and chronic low-grade inflammation. A caloric surplus increases the production of reactive oxygen species that damage cell nuclei, mitochondria and the endoplasmic reticulum. DNA damage that is insufficiently repaired leads to telomere shortening and cellular senescence, a state in which cells stop dividing but continue to secrete harmful substances. This mechanism is considered the core driver of accelerated ageing in obesity (PMID 37248754). Adipose tissue itself also ages prematurely and, through systemic inflammation and insulin resistance, contributes to damage in other organs (PMID 35379822).
A review in the European Heart Journal (2025) concludes that obesity accelerates cardiovascular ageing through molecular mechanisms shared with normal ageing. Weight reduction is seen as a key measure for reducing major cardiovascular events in older people (PMID 40197620). Childhood obesity has already been associated with premature vascular ageing, a risk that persists across the entire lifespan and is amplified in children who also develop type 2 diabetes (PMID 37256483).
An important nuance emerges from two large prospective cohorts from China (n=6730) and England (n=4713): not every type of excess weight accelerates ageing to the same degree. Metabolically unhealthy overweight or obesity, meaning people with additional metabolic disorders such as high blood sugar, high blood pressure or elevated lipid levels, was associated with a significantly faster increase in frailty (frailty index, +0.284 points per year extra, p less than 0.001). Metabolically healthy overweight or obesity, however, showed no accelerated frailty progression (PMID 36575595). The metabolic disorder therefore appears to be the driving factor, not body weight in itself.
A shift from metabolically healthy to metabolically unhealthy, regardless of weight, likewise led to clearly accelerated frailty progression in both cohorts (PMID 36575595). This underlines that monitoring metabolic health is at least as important as weight itself. Finally, obesity has been identified as a risk factor for clonal haematopoiesis (CHIP), a phenomenon in which blood stem cells carrying mutations accumulate and double cardiovascular risk, although the evidence for this is still limited and associative (PMID 34298011). Caloric restriction combined with physical exercise can partially counteract the molecular damage and slow biological ageing (PMID 37248754).
The claims are based on two large prospective cohorts, a birth cohort study, multiple review articles and an editorial. The evidence is largely associative; for cardiovascular and mechanistic outcomes there is also probable causal evidence. No randomised trials are available among the sources provided. The total participant numbers are an estimate based on the cohort sizes mentioned.